Department of Urology, Medical University of Vienna, Vienna, Austria.
Department of Urology, Ehime University Graduate School of Medicine, Ehime, Japan.
Jpn J Clin Oncol. 2021 Jul 1;51(7):1149-1157. doi: 10.1093/jjco/hyab023.
To assess the value of preoperative albumin to globulin ratio for predicting pathologic and oncological outcomes in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy in a large multi-institutional cohort.
Preoperative albumin to globulin ratio was assessed in a multi-institutional cohort of 2492 patients. Logistic regression analyses were performed to assess the association of the albumin to globulin ratio with pathologic features. Cox proportional hazards regression models were performed for survival endpoints.
The optimal cut-off value was determined to be 1.4 according to a receiver operating curve analysis. Lower albumin to globulin ratios were observed in 797 patients (33.6%) compared with other patients. In a preoperative model, low preoperative albumin to globulin ratio was independently associated with nonorgan-confined diseases (odds ratio 1.32, P = 0.002). Patients with low albumin to globulin ratios had worse recurrence-free survival (P < 0.001), cancer-specific survival (P = 0.001) and overall survival (P = 0.020) in univariable and multivariable analyses after adjusting for the effect of standard preoperative prognostic factors (recurrence-free survival: hazard ratio (HR) 1.31, P = 0.001; cancer-specific survival: HR 1.31, P = 0.002 and overall survival: HR 1.18, P = 0.024).
Lower preoperative albumin to globulin ratio is associated with locally advanced disease and worse clinical outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma. As it is difficult to stage disease entity, low preoperative serum albumin to globulin ratio may help identify those most likely to benefit from intensified care, such as perioperative systemic therapy, and the extent and type of surgery.
在一个大型多机构队列中,评估术前白蛋白与球蛋白比值对接受根治性肾输尿管切除术治疗的上尿路上皮癌患者的病理和肿瘤学结果的预测价值。
在一个多机构队列中评估了 2492 例患者的术前白蛋白与球蛋白比值。采用逻辑回归分析评估白蛋白与球蛋白比值与病理特征的相关性。采用 Cox 比例风险回归模型评估生存终点。
根据接受者操作曲线分析,确定最佳截断值为 1.4。与其他患者相比,797 例(33.6%)患者的白蛋白与球蛋白比值较低。在术前模型中,低术前白蛋白与球蛋白比值与非器官受限疾病独立相关(优势比 1.32,P=0.002)。在单变量和多变量分析中,调整标准术前预后因素的影响后,低白蛋白与球蛋白比值的患者无复发生存率(P<0.001)、癌症特异性生存率(P=0.001)和总生存率(P=0.020)更差。无复发生存率:风险比(HR)1.31,P=0.001;癌症特异性生存率:HR 1.31,P=0.002 和总生存率:HR 1.18,P=0.024)。
术前白蛋白与球蛋白比值较低与接受根治性肾输尿管切除术治疗的上尿路上皮癌患者局部晚期疾病和更差的临床结局相关。由于难以分期疾病实体,低术前血清白蛋白与球蛋白比值可能有助于识别最有可能受益于强化护理的患者,如围手术期全身治疗以及手术的范围和类型。